A recent study published in Stem Cell Research & Therapy explores the mechanisms by which extracellular vesicles (EVs) from adipose-derived stem cells (ADSCs) contribute to wound healing in diabetic models. While ADSCs-EVs have been previously associated with regenerative effects, this study aimed to clarify how they function at a molecular level.
The researchers isolated and characterized ADSCs-EVs using electron microscopy, Western blotting, and nanoparticle tracking. In in vitro experiments, the vesicles supported endothelial cell (HUVEC) migration, proliferation, and tube formation—three key processes in angiogenesis. They also influenced macrophage behavior by promoting M2 polarization, which is generally linked to tissue repair.
To test these findings in a physiological context, the team used a diabetic rat wound model. Results showed enhanced granulation tissue formation, improved angiogenesis, and faster wound closure in EV-treated wounds.
Molecular analysis via mRNA sequencing identified CCN2 (Cellular Communication Network Factor 2) as a significantly upregulated gene in the treated tissue. Additional experiments confirmed that inhibiting CCN2 expression or blocking the PI3K/AKT pathway weakened the regenerative effects observed, both in vitro and in vivo.
The findings suggest that ADSCs-EVs may exert their pro-healing influence through the CCN2/PI3K/AKT signaling axis, providing a potential direction for further research into diabetic wound therapies.
